These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 27354132)

  • 1. The Promise of the Abscopal Effect and the Future of Trials Combining Immunotherapy and Radiation Therapy.
    Johnson CB; Jagsi R
    Int J Radiat Oncol Biol Phys; 2016 Jul; 95(4):1254-6. PubMed ID: 27354132
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing equals when evaluating immunotherapy with different doses and fractions of radiation therapy.
    Gough MJ; Crittenden MR; Young KH
    Immunotherapy; 2015; 7(8):847-9. PubMed ID: 26268988
    [No Abstract]   [Full Text] [Related]  

  • 3. Using immunotherapy to boost the abscopal effect.
    Ngwa W; Irabor OC; Schoenfeld JD; Hesser J; Demaria S; Formenti SC
    Nat Rev Cancer; 2018 May; 18(5):313-322. PubMed ID: 29449659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing tumor immune response through combination of radiation and immunotherapy.
    El Chediak A; Shamseddine A; Bodgi L; Obeid JP; Geara F; Zeidan YH
    Med Oncol; 2017 Aug; 34(9):165. PubMed ID: 28828581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunotherapy and Radiation: Charting a Path Forward Together.
    Sridharan V; Schoenfeld JD
    Hematol Oncol Clin North Am; 2019 Dec; 33(6):1057-1069. PubMed ID: 31668206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The promise of combining radiation therapy and immunotherapy: morbidity and toxicity.
    Agassi AM; Myslicki FA; Shulman JM; Rotterman Y; Dosoretz DE; Fernandez E; Mantz CA; Finkelstein SE
    Future Oncol; 2014 Dec; 10(15):2319-28. PubMed ID: 25525842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials exploring the benefit of immunotherapy and radiation in cancer treatment: A review of the past and a look into the future.
    Naghavi AO; Johnstone PA; Kim S
    Curr Probl Cancer; 2016; 40(1):38-67. PubMed ID: 26656977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stereotactic ablative body radiotherapy combined with immunotherapy: present status and future perspectives.
    Rekers NH; Troost EG; Zegers CM; Germeraad WT; Dubois LJ; Lambin P
    Cancer Radiother; 2014 Oct; 18(5-6):391-5. PubMed ID: 25179250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current clinical trials testing combinations of immunotherapy and radiation.
    Crittenden M; Kohrt H; Levy R; Jones J; Camphausen K; Dicker A; Demaria S; Formenti S
    Semin Radiat Oncol; 2015 Jan; 25(1):54-64. PubMed ID: 25481267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triggering the Abscopal Effect: Is the Quality of the Radiation Important?
    Vernimmen FJ; Nicholson JT
    Int J Radiat Oncol Biol Phys; 2017 Aug; 98(5):1162-1163. PubMed ID: 28721900
    [No Abstract]   [Full Text] [Related]  

  • 11. The Abscopal Effect in the Era of Cancer Immunotherapy: a Spontaneous Synergism Boosting Anti-tumor Immunity?
    Hlavata Z; Solinas C; De Silva P; Porcu M; Saba L; Willard-Gallo K; Scartozzi M
    Target Oncol; 2018 Apr; 13(2):113-123. PubMed ID: 29470785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combining radiotherapy with immunotherapy: the past, the present and the future.
    Van Limbergen EJ; De Ruysscher DK; Olivo Pimentel V; Marcus D; Berbee M; Hoeben A; Rekers N; Theys J; Yaromina A; Dubois LJ; Lambin P
    Br J Radiol; 2017 Aug; 90(1076):20170157. PubMed ID: 28541096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Time to abandon single-site irradiation for inducing abscopal effects.
    Brooks ED; Chang JY
    Nat Rev Clin Oncol; 2019 Feb; 16(2):123-135. PubMed ID: 30401936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combining radiotherapy with immunotherapy for urological malignancies].
    Rieken S; El Shafie R
    Urologe A; 2018 Nov; 57(11):1309-1315. PubMed ID: 30324394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mathematical Modeling of Cancer Immunotherapy and Its Synergy with Radiotherapy.
    Serre R; Benzekry S; Padovani L; Meille C; André N; Ciccolini J; Barlesi F; Muracciole X; Barbolosi D
    Cancer Res; 2016 Sep; 76(17):4931-40. PubMed ID: 27302167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local radiotherapy and granulocyte-macrophage colony-stimulating factor to generate abscopal responses in patients with metastatic solid tumours: a proof-of-principle trial.
    Golden EB; Chhabra A; Chachoua A; Adams S; Donach M; Fenton-Kerimian M; Friedman K; Ponzo F; Babb JS; Goldberg J; Demaria S; Formenti SC
    Lancet Oncol; 2015 Jul; 16(7):795-803. PubMed ID: 26095785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy.
    Deutsch E; Chargari C; Galluzzi L; Kroemer G
    Lancet Oncol; 2019 Aug; 20(8):e452-e463. PubMed ID: 31364597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Should we be combining local tumor therapies with immunotherapies as standard?
    Baues C; Schlaak M; von Bergwelt-Baildon M; Theurich S
    Future Oncol; 2017 Aug; 13(18):1573-1575. PubMed ID: 28829189
    [No Abstract]   [Full Text] [Related]  

  • 19. Combining radiation and immunotherapy: a new systemic therapy for solid tumors?
    Tang C; Wang X; Soh H; Seyedin S; Cortez MA; Krishnan S; Massarelli E; Hong D; Naing A; Diab A; Gomez D; Ye H; Heymach J; Komaki R; Allison JP; Sharma P; Welsh JW
    Cancer Immunol Res; 2014 Sep; 2(9):831-8. PubMed ID: 25187273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy with radiotherapy in urological malignancies.
    Mehta S; Illidge T; Choudhury A
    Curr Opin Urol; 2016 Nov; 26(6):514-22. PubMed ID: 27552139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.